Pfizer submitted data on COVID vaccine large-scale phase 3 trial to EU drug Regulator
Leaders from AAP, BJP, and Congress were invited to put forward their points. The alarming rise in Covid cases indicates...
Latest Post
Amazon steps into the American digital pharma market
Amazon has ventured into the US pharmaceutical arena by launching Amazon Pharmacy. THD NewsDesk, US: On November 17, Amazon announced...
US scientists discover unique way of spotting Alzheimer’s through Retinal images
Cedars-Sinai Medical Centre has made a scientific advancement relating to Alzheimer's disease. Their research deduced that retinal image studies could...
‘Outsiders’ increasing the COVID-19 cases in the Capital- Delhi Minister
Aggressive testing of people, 25-30% of whom were not residents of the capital. Most patients from other states arrive here...
Xi Jinping proposes to assist India and other BRICS countries to advance COVID-19 vaccine
Chinese President Xi Jinping proposed to assist India and other BRICS nations in the advancement of vaccines. The WHO has...
SC rejects AAP’s plea to reserve 80% ICU beds for Covid patients
The SC has refused to lift the Delhi HC's stay on the AAP government's direction to 33 private hospitals. The...
Newly-elected US Prez Biden asks for coordination from Trump on US vaccination programme
Former US President Trump and newly-elected Biden are in a clash over the transfer of charge. Biden has warned Trump...
Moderna’s Covid vaccine candidate boasts of 94.5% efficacy rate
DMSB had undertaken the Phase-3, COVE study for Moderna's mRNA vaccine The vaccine gave a 94.5% efficacy rate. EMA to...
US FDA authorises this antibody therapy for treatment of mild Covid-19 infection
The therapy has been found effective in treating coronavirus patients with mild-to-moderate illness It can reduce hospitalisation rates and the...
Samsung BioLogics mass-producing Eli Lilly’s COVID-19 remedy
Samsung BioLogics Co Ltd stated it is mass-producing a COVID-19 antibody medication. The FDA affirmed the drug 'bamlanivimab' after clinical...
